Handbook of Experimental Immunology

TLDR

Cancer treatment requires proven quality, safety, and efficacy, with new measures evaluated through level I randomized controlled trials or level II cohort studies, and evidence‑based therapy follows international expert panel recommendations such as surgery, chemotherapy, radiotherapy, hormone, and antibody therapy. The review aims to provide an overview of complementary therapies recommended to support and optimise standard evidence‑based cancer treatments. The review synthesises these complementary therapies by compiling and discussing evidence from relevant studies. These therapies have all proven their potency to destroy cancer and their curative feasibility.

Abstract

Cancer diseases demand diagnostic and therapeutic measures with proven quality, safety and efficacy. Bases for evaluation of new clinical and therapeutic measures are clinical studies representing level I (randomised controlled trials [RCTs]) or level II (epidemiological cohort studies), in accordance with recommendations of the Centre for Evidence-Based Medicine, University of Oxford, UK. Evidence-based treatment of cancer follows recommendations of international expert panels and includes indication-based surgery, chemotherapy, radiotherapy, hormone and antibody therapy. These therapies have all proven their potency to destroy cancer and their curative feasibility. This review provides an overview of some of the complementary therapies that are also recommended to support and optimise the standard evidence based cancer treatments.